about
The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosisAmyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signalingQuantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosisNeural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot studyAdvances in mechanisms of genetic instability related to hereditary neurological diseases.Solubilization and disaggregation of polyglutamine peptidesHuntington's diseaseGenetics beyond Mendel. Understanding nontraditional inheritance patterns.Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells.Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse modelDegenerative Encephalopathy in Nova Scotia Duck Tolling Retrievers Presenting with a Rapid Eye Movement Sleep Behavior Disorder.Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicityMultiple antioxidants in the prevention and treatment of Parkinson's disease.Molecules of the brain.α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.Proteases for cell suicide: functions and regulation of caspases.A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.Conformational Abs recognizing a generic amyloid fibril epitope.Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation.Enantioselective total synthesis of (-)-jiadifenolide.Hsp70 and its molecular role in nervous system diseasesMedical genetics: 3. An approach to the adult with a genetic disorder.Caspases in Huntington's disease.Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.Protein-misfolding diseases and chaperone-based therapeutic approaches.Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation?TDP-43 toxicity proceeds via calcium dysregulation and necrosis in aging Caenorhabditis elegans motor neurons.Friedreich's ataxia.Genetics 101: detecting mutations in human genesRisk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.Enantioselective synthesis of (-)-jiadifenin, a potent neurotrophic modulatorFGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disordersGenetics of neurological disorders.Protein misfolding in neurodegenerative diseases.Bacillus thuringiensis Crystal Protein Cry6Aa Triggers Caenorhabditis elegans Necrosis Pathway Mediated by Aspartic Protease (ASP-1).Misfolded proteins, endoplasmic reticulum stress and neurodegeneration.Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's diseaseGemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders
P2860
Q23917508-A5F2F826-FEDC-4F6E-BF4B-D4070848A9DDQ24292067-20A2FE89-F7FF-4FBC-B9FD-B5E17088B76DQ24297593-CAD5CABD-4D45-411C-B739-E06C5DE15338Q24596119-84A102E3-E7CC-4953-B620-0C6E3CC1B569Q24816457-D045D9A8-B53A-4001-9401-D3ECD3F7CE4CQ28361593-C5B86C8D-AD86-4247-8260-76AE20E2B7B4Q28365461-C2A3A46C-F8F9-45B1-8A30-1EADD0C3E406Q30306139-0D60968F-6FD5-40AB-83CE-3C84EB5DD699Q30497111-CB5A9E01-228A-4380-AB1C-735B702B5288Q30650444-C5979721-13EF-41B5-A91C-7B2F66EA21AAQ31135562-C9CD75A8-2D43-46EA-8F50-AD1A1AFEA8BCQ33280345-AE534E8B-9163-4D40-88AF-0AC0C72744A3Q33746725-FF3109DB-1F36-4A82-83DF-52FFE642F49EQ33846594-7CD2115A-201B-4E4B-8D5F-51730EDE8E88Q33889446-FCEE23F7-0E2D-47B0-9BA6-B47D57AE2F66Q33927179-C3AB6133-B6F1-4D5E-BAAE-8E94FCDE9629Q33999486-5917F537-6162-4D4B-91BE-B6457BCB789AQ34009881-DF0526E2-3248-45AC-8792-EB5A5D1F9DCDQ34080448-580C9FAB-6DDC-4898-8E03-0718943E456FQ34154622-1BAE3137-09E3-4132-B5CE-5ECC10A89642Q34170520-8D74CC21-9F3E-4077-BD0E-7AD0E9F47F0FQ34170760-5C5CF033-6F60-441F-B54E-5F54995B6D0AQ34289457-706F22D0-22D7-40DC-834D-54755109AEC3Q34476762-7326C880-F548-4BF5-B067-4B773AC42CA5Q34489852-312232AD-13CB-4152-8A0A-8BA4075ECE93Q34524526-E1682ED3-5199-4B6B-AED8-63D3605BD639Q34626028-47B5D9A6-0224-415D-9BDF-6F3D31C8FA13Q34674858-29ADDCCC-9C03-4ECE-BBF1-A2A51D0A51DAQ34768416-30B9C1C8-E9C1-49C9-A6A6-80158AEE2A64Q34788762-154C872E-6EE2-457A-8C48-6D0E3D6A9E1CQ35025023-50EB1C83-FFAE-4489-B029-82853C2F1993Q35169533-29B49716-54CF-4E3F-8BB7-E1FE136377ECQ35184517-496CDD3E-9054-46EE-BA27-A9D1EA6D23F0Q35621081-45AA674D-833A-4659-A025-ACDBBB296257Q35770559-24E7EE20-F60B-4C29-AA57-2404FBC1AE3EQ35790921-D57EDA32-F755-426E-BBF4-623B242CE788Q35900236-A8DCD287-FBCE-4234-AF3C-BB4B6658AD27Q35941821-01DBFED5-BD2C-49AF-8513-09B788490264Q36004699-DC9BC8FD-AA07-4F0A-A687-01EBAEFF4B5EQ36137520-6D63C9A6-5962-4B15-AEAE-7649EE861CBB
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular basis of the neurodegenerative disorders.
@ast
Molecular basis of the neurodegenerative disorders.
@en
type
label
Molecular basis of the neurodegenerative disorders.
@ast
Molecular basis of the neurodegenerative disorders.
@en
prefLabel
Molecular basis of the neurodegenerative disorders.
@ast
Molecular basis of the neurodegenerative disorders.
@en
P1476
Molecular basis of the neurodegenerative disorders.
@en
P2093
P304
P356
10.1056/NEJM199906243402507
P407
P577
1999-06-01T00:00:00Z